There are a number of errors in the caption for Fig 3, “Ingenuity pathway analysis of concordantly changed mRNAs from Table 3,” panels A-D. Please see the complete, correct Fig 3 caption here.
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Fig 3. Ingenuity pathway analysis of concordantly changed mRNAs from Table 3.
Colors indicate predicted effect of transcript on biological function or disease in center of circular diagram. (A) Failure of heart. (B) Dysfunction of heart. (C) Cell death of heart. (D) Fibrosis of heart.
https://doi.org/10.1371/journal.pone.0224389.g001
The caption listed within Supporting Information file S1 Text is incorrect. Additionally, there are a number of errors in the gene names in S2 Table, S3 Table and S4 Table. Please view the correct S1 Text, S2 Table, S3 Table and S4 Table below.
Note, there is an error in the caption for S3 Table. Please see the complete, correct S3 Table caption below.
Supporting information
Showing 1/4: pone.0224389.s001.docx
S1 Text
. List of abbreviations and acronyms.
A-S
- All-subjects cohort, N = 47 (31 Responders and 11 Nonresponders)
C
cpT
-
Total Cross-Platform Concordance
C
ccT
- Total Cross-cohort concordance
DEG
- Differentially expressed genes
FPKM
- Fragments per kilobase of transcript per million mapped reads
HFrEF
-
Heart failure with reduced left ventricular ejection fraction
HFpEF
- Heart failure with preserved left ventricular ejection fraction
IPA
- Ingenuity Pathway Analysis
LVEF
- Left ventricular ejection fraction
LOCF
- last observation carried forward
NR
– Nonresponder for reverse remodeling, not meeting the definition of Responder in the A-S
cohort
POG
-
Percentage of overlapping genes
R
- Responder for reverse remodeling, predefined as an LVEF increase from baseline at 3
months of ≥5 absolute %, or an increase at 12 months of ≥8 absolute %.
R/NR
- Responder mRNA abundance change from baseline/Nonresponder change
RVEF
- Right ventricular ejection fraction
SAMGE-PC
- sequential analysis of myocardial gene expression with phenotypic change
S-R
-
Super-Responder subcohort, N = 12 (6 Super-Responders and 6 Nonresponders)
SR
- Super-Responder for reverse remodeling, predefined as an LVEF increase from baseline
at 3 or 12 months of ≥10 absolute %
figshare
1 / 4
Download
(DOCX)
S1 Text. List of abbreviations and acronyms.
https://doi.org/10.1371/journal.pone.0224389.s001
(DOCX)
S2 Table. Up or downregulated genes within the R and R/NR analyses, microarray or RNA-Seq measurements in the S-R cohort.
https://doi.org/10.1371/journal.pone.0224389.s002
(DOCX)
S3 Table. Biologic categories of 299 concordant gene expression changes identified in the R/NR analysis by microarray and RNA-Seq in the S-R cohort (Table 3), and RT-qPCR and RNA-Seq in the S-R cohort (Table 2).
https://doi.org/10.1371/journal.pone.0224389.s003
(DOCX)
S4 Table. Up or downregulated genes within the R and R/NR analyses, microarray measurements in the A-S cohort.
https://doi.org/10.1371/journal.pone.0224389.s004
(DOCX)
1. Toni LS, Carroll IA, Jones KL, Schwisow JA, Minobe WA, Rodriguez EM, et al. (2019) Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance. PLoS ONE 14(8): e0221519. https://doi.org/10.1371/journal.pone.0221519 pmid:31469842
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2019 Toni et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.